- Home
- CNC vs BAX Comparison
CNC vs BAX Comparison
Compare CNC & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNC | BAX |
|---|---|---|
| Founded | 1984 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.5B | 9.4B |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNC | BAX |
|---|---|---|
| Price | $38.37 | $18.60 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 17 | 10 |
| Target Price | ★ $40.06 | $25.67 |
| AVG Volume (30 Days) | ★ 8.4M | 8.3M |
| Earning Date | 10-29-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 0.22% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $167,680,000,000.00 | $11,023,000,000.00 |
| Revenue This Year | $32.54 | $5.20 |
| Revenue Next Year | $0.19 | $2.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.57 | 3.90 |
| 52 Week Low | $25.08 | $17.40 |
| 52 Week High | $66.81 | $37.74 |
Technical Indicators
Market Signals| Indicator | CNC | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 55.23 | 43.20 |
| Support Level | $37.41 | $18.33 |
| Resistance Level | $39.34 | $19.17 |
| Average True Range (ATR) | 1.38 | 0.54 |
| MACD | 0.07 | 0.21 |
| Stochastic Oscillator | 70.49 | 63.23 |
Price Performance
Historical ComparisonAbout CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.